Paeds · ophthalmology
Leukocoria and retinoblastoma
Also known as White pupillary reflex · Cat-eye reflex · Retinoblastoma · RB1 tumour suppressor gene · Two-hit hypothesis · International Intraocular Retinoblastoma Classification · Trilateral retinoblastoma · Ophthalmic artery chemosurgery
Fellowship guide to leukocoria and retinoblastoma in children. Covers the white pupillary reflex as the red-flag sign, the differential diagnosis of leukocoria from the retinoblastoma through the congenital cataract, the Coats disease, the retinopathy of prematurity and the toxocariasis, the RB1 tumour suppressor gene on chromosome thirteen and the Knudson two-hit hypothesis, the heritable and the non-heritable forms, the International Intraocular Retinoblastoma Classification of groups A through E, the imaging with ultrasound and magnetic resonance imaging, the urgent referral to the ocular oncology centre, the risk-adapted treatment from the focal laser and cryotherapy through the ophthalmic artery chemosurgery and the systemic chemotherapy to the enucleation, the trilateral retinoblastoma and its poor prognosis, and the survivorship surveillance for the second malignancy and the late effects.
On this page & tools
Your progress
Saved locally on this device.
Practise this topic
Target exams
Red flags
Life stages
Care settings
Clinical exam formats
Board mappings
Overview & Definition
A parent sees a white glow in the pupil of their infant in the flash of a photograph, and the family is unsettled by something they cannot name. A general practitioner performs the red reflex at the six-week check and finds a yellow-white reflex where there should be a warm orange-red. Both have met leukocoria, the white pupillary reflex, and the most important single sign in paediatric ophthalmology, because behind it may sit retinoblastoma, the commonest primary intraocular malignancy of childhood. The clinician who sees the white pupil and moves to the urgent referral without delay is the clinician who saves the eye and the life, because the early retinoblastoma is one of the most curable of all childhood cancers and the late retinoblastoma is one of the most lethal. [1][2]
Retinoblastoma is a tumour of the developing retina that arises from the immature cone-precursor cell, and it is driven by the loss of both copies of the RB1 tumour suppressor gene on the long arm of chromosome thirteen. The disease sits at the intersection of the paediatrics, ophthalmology, oncology and the clinical genetics, because it is at once a cancer, a genetic disease and a model of the tumour suppressor gene. The Knudson two-hit hypothesis, proposed by Alfred Knudson in nineteen-seventy-one to explain the age and the laterality of retinoblastoma, gave the world the concept of the tumour suppressor gene, and it is one of the most consequential ideas in all of oncology. The candidate who can hold the biology, classification, staging and the treatment in one frame holds the whole topic. [1][5][6]
The clinical gravity of the disease is concentrated in the speed of the referral and in the resource of the country. In the high-income setting, where the red reflex is checked at the newborn examination and the well-child visits, the retinoblastoma presents with the leukocoria or the strabismus, the disease is confined to the eye, and the survival is above ninety-five percent. In the low-income setting, where the red reflex is not checked and the specialist is far, the retinoblastoma presents with the proptosis, the orbital cellulitis or the intracranial spread, and the survival is below forty percent. The Global Retinoblastoma Study of the JAMA Oncology, which analysed over four thousand children across the world, showed that the single greatest determinant of the outcome of retinoblastoma is the national income, and it is the fact that the boards reward the candidate who can name. [2][3]
You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References10Show ledgerHide ledger
- [1]Dimaras H, Corson TW, Cobrinik D, et al. Retinoblastoma. Nat Rev Dis Primers, 2015.PMID 27189421
- [2]Fabian ID, Abdallah E, Abdullahi SU, et al. Global Retinoblastoma Presentation and Analysis by National Income Level. JAMA Oncol, 2020.PMID 32105305
- [3]Dimaras H, Corson TW Retinoblastoma, the visible CNS tumor: A review. J Neurosci Res, 2019.PMID 29314142
- [4]Thériault BL, Dimaras H, Gallie BL, et al. The genomic landscape of retinoblastoma: a review. Clin Exp Ophthalmol, 2014.PMID 24433356
- [5]Chernoff J The two-hit theory hits 50. Mol Biol Cell, 2021.PMID 34735271
- [6]Mastrangelo D, De Francesco S, Di Leonardo A, et al. The retinoblastoma paradigm revisited. Med Sci Monit, 2008.PMID 19043380
- [7]Sábado Alvarez C Molecular biology of retinoblastoma. Clin Transl Oncol, 2008.PMID 18628066
- [8]Rodjan F, de Graaf P, Brisse HJ, et al. Trilateral retinoblastoma: neuroimaging characteristics and value of routine brain screening on admission. J Neurooncol, 2012.PMID 22802019
- [9]Mouratova T Trilateral retinoblastoma: a literature review, 1971-2004. Bull Soc Belge Ophtalmol, 2005.PMID 16281731
- [10]Taich P, Requejo F, Asprea M, et al. Topotecan Delivery to the Optic Nerve after Ophthalmic Artery Chemosurgery. PLoS One, 2016.PMID 26959658